APA (7th ed.) Citation

Verma, C., Eremin, J. M., Robins, A., Bennett, A. J., Cowley, G. P., El-Sheemy, M. A., . . . Eremin, O. (2013). Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC. BioMed Central.

Chicago Style (17th ed.) Citation

Verma, Chandan, Jennifer M. Eremin, Adrian Robins, Andrew J. Bennett, Gerard P. Cowley, Mohamed A. El-Sheemy, Jibril A. Jibril, and Oleg Eremin. Abnormal T Regulatory Cells (Tregs: FOXP3+, CTLA-4+), Myeloid-derived Suppressor Cells (MDSCs: Monocytic, Granulocytic) and Polarised T Helper Cell Profiles (Th1, Th2, Th17) in Women with Large and Locally Advanced Breast Cancers Undergoing Neoadjuvant Chemotherapy (NAC) and Surgery: Failure of Abolition of Abnormal Treg Profile with Treatment and Correlation of Treg Levels with Pathological Response to NAC. BioMed Central, 2013.

MLA (9th ed.) Citation

Verma, Chandan, et al. Abnormal T Regulatory Cells (Tregs: FOXP3+, CTLA-4+), Myeloid-derived Suppressor Cells (MDSCs: Monocytic, Granulocytic) and Polarised T Helper Cell Profiles (Th1, Th2, Th17) in Women with Large and Locally Advanced Breast Cancers Undergoing Neoadjuvant Chemotherapy (NAC) and Surgery: Failure of Abolition of Abnormal Treg Profile with Treatment and Correlation of Treg Levels with Pathological Response to NAC. BioMed Central, 2013.